Evogene Ltd.

REHOVOT, L3 · Agritech · Public

Computational biology platform for accelerated life-science product development

Claim this profile

Follows are private to you and power your alerts

Updated · evogene.com

Sector
Agritech
Headquarters
REHOVOT, L3
Latest Form D
$3.4M, Feb 2026
Total capital
$3.4M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$3.4M
2 Form D · last Feb 2026
8 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
21
19 pending · first 2022
Rank in peer group#1 of 52

Capital timeline

202420252026FEDERAL ↑EQUITY ↓Cumulative $15.4M1st Form D$12M2nd Form D$3.4M
202420252026FEDERAL ↑EQUITY ↓Cumulative $15.4M1st Form D$12M2nd Form D$3.4M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$3.4M
  • Offering registeredForm D · SEC · 1st filing$12M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 52 peers

Line = median

Agritech · Platform

  • Granted patents#1 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Adrian PercyDirectorNamed in SEC Form D filings
  • Dan FalkDirectorNamed in SEC Form D filings
  • Eyal RonenExecutive OfficerNamed in SEC Form D filings
  • Gabi TarcicExecutive OfficerNamed in SEC Form D filings
  • Ilia ZhidkovExecutive OfficerNamed in SEC Form D filings
  • Leon Y. RecanatiDirectorNamed in SEC Form D filings
Show all 13 people
  • Mark KapelExecutive OfficerNamed in SEC Form D filings
  • Nir NimrodiDirectorNamed in SEC Form D filings
  • Oded Y. ShoseyovDirectorNamed in SEC Form D filings
  • Ofer HavivExecutive OfficerNamed in SEC Form D filings
  • Sarit FironDirectorNamed in SEC Form D filings
  • Sassi MasliahExecutive OfficerNamed in SEC Form D filings
  • Yaron EldadExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 21 granted of 40
  • PendingPolynucleotides And Polypeptides Of Plant And Bacterial Origin For Protecting Plants From Pathogenic FungiUSPTOApplication 18360543
  • PendingInsecticidal Polypeptides And Use ThereofUSPTOApplication 18512873
  • GrantedInsecticidal Polypeptides And Use ThereofUSPTOUS 11,859,197
Show all 40 patent records

Regulatory activity · Agritech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .